Literature DB >> 23840054

Measuring cognitive change in subjects with prodromal Alzheimer's disease.

T Mura1, C Proust-Lima, H Jacqmin-Gadda, T N Akbaraly, J Touchon, B Dubois, C Berr.   

Abstract

OBJECTIVE: To investigate the sensitivity of a large set of neuropsychological tests to detect cognitive changes due to prodromal Alzheimer's disease(AD); to compare their metrological properties in order to select a restricted number of these tests for the longitudinal follow-up of subjects with prodromal AD. PARTICIPANTS: 212 patients with mild cognitive impairment were tested at baseline by a standardised neuropsychological battery, which included: the Free and Cued Selective Reminding test (FCSRT), the Benton Visual Retention test, the Deno100, verbal fluency, a serial digit learning test, the double task of Baddeley, the Wechsler Adult Intelligence Scale (WAIS) similarities, the Trail-Making Test and the WAIS digit symbol test. Patients were monitored every 6 months for up to 3 years in order to identify those who converted to AD (retrospectively classified as prodromal AD). Statistical analyses were performed using a nonlinear multivariate mixed model involving a latent process. This model assumes that the psychometric tests are nonlinear transformations of a common latent cognitive process, and it captures the metrological properties of tests.
RESULTS: 57 patients converted to AD. The most sensitive tests in the detection of cognitive changes due to prodromal AD were the FCSRT, the semantic verbal fluency and the Deno100. Some tests exhibited a higher sensitivity to cognitive changes for subjects with high levels of cognition, such as the free recall, delayed free recall scores of the FCSRT and the semantic verbal fluency, whereas others showed a higher sensitivity at low levels of cognition, such as the total recall score of the FCSRT.
CONCLUSIONS: Tests used for the follow-up of prodromal AD subjects should be chosen among those that actually decline in this stage of the disease and should be selected according to the subject's initial scores.

Entities:  

Keywords:  Alzheimer's Disease; Cognitive Neuropsychology; Dementia; Statistics

Mesh:

Year:  2013        PMID: 23840054      PMCID: PMC5225268          DOI: 10.1136/jnnp-2013-305078

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  31 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

3.  Revised criteria for mild cognitive impairment: validation within a longitudinal population study.

Authors:  Sylvaine Artero; Ronald Petersen; Jacques Touchon; Karen Ritchie
Journal:  Dement Geriatr Cogn Disord       Date:  2006-10-13       Impact factor: 2.959

4.  Influence of APOE status on lexical-semantic skills in mild cognitive impairment.

Authors:  Roberta Biundo; Simona Gardini; Paolo Caffarra; Letizia Concari; Davide Martorana; Tauro Maria Neri; Michael F Shanks; Annalena Venneri
Journal:  J Int Neuropsychol Soc       Date:  2011-05       Impact factor: 2.892

5.  Designing clinical trials for early (pre-dementia) Alzheimer's disease: determining the appropriate population for treatment.

Authors:  E Siemers
Journal:  J Nutr Health Aging       Date:  2011-01       Impact factor: 4.075

6.  Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease.

Authors:  Stephen F Carter; Diana Caine; Alistair Burns; Karl Herholz; Matthew A Lambon Ralph
Journal:  Int J Geriatr Psychiatry       Date:  2011-05-25       Impact factor: 3.485

7.  The Set test as an aid to the detection of dementia in old people.

Authors:  B Isaacs; A T Kennie
Journal:  Br J Psychiatry       Date:  1973-10       Impact factor: 9.319

8.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

9.  Norms for change in episodic memory as a prerequisite for the diagnosis of mild cognitive impairment (MCI).

Authors:  Stefan Bläsi; Antoinette E Zehnder; Manfred Berres; Kirsten I Taylor; René Spiegel; Andreas U Monsch
Journal:  Neuropsychology       Date:  2009-03       Impact factor: 3.295

10.  Semantic knowledge in mild cognitive impairment and mild Alzheimer's disease.

Authors:  Anna-Lynne R Adlam; Sasha Bozeat; Robert Arnold; Peter Watson; John R Hodges
Journal:  Cortex       Date:  2006-07       Impact factor: 4.027

View more
  20 in total

Review 1.  Early neuropsychological detection of Alzheimer's disease.

Authors:  C Bastin; E Salmon
Journal:  Eur J Clin Nutr       Date:  2014-09-03       Impact factor: 4.016

2.  Two-stage screening for early dementia in primary care.

Authors:  Ellen Grober; Wenzhu Bi Mowrey; Amy R Ehrlich; Peter Mabie; Steven Hahn; Richard B Lipton
Journal:  J Clin Exp Neuropsychol       Date:  2016-06-07       Impact factor: 2.475

3.  Free and cued selective reminding test predicts progression to Alzheimer's disease in people with mild cognitive impairment.

Authors:  Giulia Grande; Nicola Vanacore; Davide L Vetrano; Ilaria Cova; Debora Rizzuto; Flavia Mayer; Laura Maggiore; Roberta Ghiretti; Valentina Cucumo; Claudio Mariani; Stefano F Cappa; Simone Pomati
Journal:  Neurol Sci       Date:  2018-07-26       Impact factor: 3.307

4.  Study protocol for the Alzheimer and music therapy study: An RCT to compare the efficacy of music therapy and physical activity on brain plasticity, depressive symptoms, and cognitive decline, in a population with and at risk for Alzheimer's disease.

Authors:  Birthe K Flo; Anna Maria Matziorinis; Stavros Skouras; Tobba Therkildsen Sudmann; Christian Gold; Stefan Koelsch
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

Review 5.  Immunogenicity of DNA- and recombinant protein-based Alzheimer disease epitope vaccines.

Authors:  Hayk Davtyan; Andrew Bacon; Irina Petrushina; Karen Zagorski; David H Cribbs; Anahit Ghochikyan; Michael G Agadjanyan
Journal:  Hum Vaccin Immunother       Date:  2014-02-13       Impact factor: 3.452

Review 6.  Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms.

Authors:  Amelia J Anderson-Mooney; Frederick A Schmitt; Elizabeth Head; Ira T Lott; Kenneth M Heilman
Journal:  Brain Cogn       Date:  2016-02-27       Impact factor: 2.310

7.  Coupled changes in brain white matter microstructure and fluid intelligence in later life.

Authors:  Stuart J Ritchie; Mark E Bastin; Elliot M Tucker-Drob; Susana Muñoz Maniega; Laura E Engelhardt; Simon R Cox; Natalie A Royle; Alan J Gow; Janie Corley; Alison Pattie; Adele M Taylor; Maria Del C Valdés Hernández; John M Starr; Joanna M Wardlaw; Ian J Deary
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

8.  Pattern and Rate of Cognitive Decline in Cerebral Small Vessel Disease: A Prospective Study.

Authors:  Andrew J Lawrence; Rebecca L Brookes; Eva A Zeestraten; Thomas R Barrick; Robin G Morris; Hugh S Markus
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

9.  Exploring anterograde memory: a volumetric MRI study in patients with mild cognitive impairment.

Authors:  N Philippi; V Noblet; E Duron; B Cretin; C Boully; I Wisniewski; M L Seux; C Martin-Hunyadi; E Chaussade; C Demuynck; S Kremer; S Lehéricy; D Gounot; J P Armspach; O Hanon; F Blanc
Journal:  Alzheimers Res Ther       Date:  2016-07-30       Impact factor: 6.982

10.  COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.

Authors:  Ruth de Diego-Balaguer; Catherine Schramm; Isabelle Rebeix; Emmanuel Dupoux; Alexandra Durr; Alexis Brice; Perrine Charles; Laurent Cleret de Langavant; Katia Youssov; Christophe Verny; Vincent Damotte; Jean-Philippe Azulay; Cyril Goizet; Clémence Simonin; Christine Tranchant; Patrick Maison; Amandine Rialland; David Schmitz; Charlotte Jacquemot; Bertrand Fontaine; Anne-Catherine Bachoud-Lévi
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.